ADVANCES IN THE MANAGEMENT OF NAUSEA AND VOMITING INDUCED BY NON-CISPLATIN CONTAINING CHEMOTHERAPEUTIC REGIMENS

被引：5

作者：

GRUNBERG, SM

机构：

来源：

BLOOD REVIEWS | 1989年 / 3卷 / 04期

关键词：

D O I：

10.1016/0268-960X(89)90029-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：216 / 221

页数：6

共 59 条

[1] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].

AAPRO, MS ;

PLEZIA, PM ;

ALBERTS, DS ;

GRAHAM, V ;

JONES, SE ;

SURWIT, EA ;

MOON, TE .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471

[2]

AKTINS JN, 1985, CANCER TREATMENT REP, V69, P897

[3] DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE - EFFICACY IN CONTROLLING CISPLATIN INDUCED NAUSEA AND VOMITING [J].

ALLAN, SG ;

CORNBLEET, MA ;

WARRINGTON, PS ;

GOLLAND, IM ;

LEONARD, RCF ;

SMYTH, JF .

BRITISH MEDICAL JOURNAL, 1984, 289 (6449) :878-879

[4] ADVANCES IN ANTI-EMETIC THERAPY [J].

BAKOWSKI, MT .

CANCER TREATMENT REVIEWS, 1984, 11 (03) :237-256

[5]

BERKOWITZ DM, 1980, CLIN PHARMACOL THER, V27, P414, DOI 10.1038/clpt.1980.55

[6] NEUROPHARMACOLOGY OF CHEMOTHERAPY-INDUCED EMESIS [J].

BORISON, HL ;

MCCARTHY, LE .

DRUGS, 1983, 25 :8-17

[7] ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY [J].

BOWCOCK, SJ ;

STOCKDALE, AD ;

BOLTON, JAR ;

KANG, AA ;

RETSAS, S .

BRITISH MEDICAL JOURNAL, 1984, 288 (6434) :1879-1879

[8] THE ANTIEMETIC EFFICACY OF METHYLPREDNISOLONE COMPARED WITH METOCLOPRAMIDE IN OUTPATIENTS RECEIVING ADJUVANT CMF CHEMOTHERAPY FOR BREAST-CANCER - A RANDOMIZED TRIAL [J].

CAMPORA, E ;

CHIARA, S ;

BRUZZI, P ;

SCARSI, P ;

ROSSO, R .

TUMORI JOURNAL, 1985, 71 (05) :459-462

[9]

CAPIZZI RL, 1984, BLOOD, V63, P694

[10] A COMPARISON OF THE ANTIEMETIC EFFICACY OF PROCHLORPERAZINE AND METOCLOPRAMIDE FOR THE TREATMENT OF CISPLATIN-INDUCED EMESIS - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY [J].

CARR, BI ;

BERTRAND, M ;

BROWNING, S ;

DOROSHOW, JH ;

PRESANT, C ;

PULONE, B ;

HILL, LR .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1127-1132

← 1 2 3 4 5 6 →